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Background: Absence of the inferior vena cava is a rare vascular anomaly, which usually remains asymptomatic in
childhood. It is recognized as the risk factor for deep venous thrombosis, since the collateral circulation does not
provide adequate drainage of the lower limbs. Mycoplasma pneumoniae is a common cause of community-acquired
pneumonia in school-aged children and adolescents. Mycoplasma pneumoniae infection might be associated with
deep venous thrombosis but its pathophysiology remains unknown. According to previous reports, deep venous
thrombosis due to Mycoplasma pneumoniae infection is associated with positive serum anticardiolipin antibodies.
To our knowledge, we describe the first case of deep venous thrombosis associated with Mycoplasma pneumoniae
serum antibodies indicating early stage of infection with negative anticardiolipin serum antibodies in adolescent with
absence of inferior vena cava.
Case presentation: 14-year old boy was admitted to the pediatric unit few days after the appendectomy complaining
with pain of the left hip that caused him unable to walk. The pain was accompanied with subfebrile temperature.
After clinical examination and additional tests, the boy was diagnosed with a deep venous thrombosis. Computed
tomography revealed absence of the vena cava inferior distally to the hepatic veins and varices of the collateral
circulation in the pelvis. Anticardiolipin IgM and IgG antibodies and antinuclear antibodies were not detected.
Additionally, the Mycoplasma pneumoniae antibodies in classes IgM, IgA and IgG were detected in serum as
another risk factor of thrombosis. After the initial treatment with low-molecular-weight heparin in combination
with clarithromycin the clinical condition of the patient improved. The patient became a candidate for life-long
anticoagulation therapy.
Conclusions: In this case Mycoplasma pneumoniae antibodies were associated with deep venous thrombosis in
child with congenital absence of inferior vena cava. Uncommonly for deep venous thrombosis due to Mycoplasma
pneumoniae infection, anticardiolipin antibodies were not detected in serum. It is important to remember in clinical
practice that Mycoplasma pneumoniae affects coagulability and may trigger thrombosis, especially in the presence of
other risk factors. The pathophysiology of this process remains unknown.
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Congenital absence of the inferior vena cava (AIVC) is a
rare vascular anomaly, often asymptomatic and iden-
tified serendipitously. Because AIVC is a defect that
cannot be detected using b-mode USG, its prevalence is
underestimated. The prevalence of AIVC has been esti-
mated at 0.6-4% but some researches based on CT and/
or MRI reported that AIVC may be present in 5–9.5%
of young subjects with venous thrombosis. None of
these studies evaluated AIVC prevalence in the general
population [1,2]. Inferior vena cava (IVC) anomalies,
including AIVC, are increasingly being recognized as the
risk factors for deep vein thrombosis (DVT), since the
collateral circulation does not provide adequate drainage
of the lower limbs. Thrombosis associated with AIVC is
often reported as a bilateral DVT that occurs in young
adults, much younger than the mean age of DVT pres-
entation [1]. Because the immature coagulation system is
not promoting thrombosis, AIVC usually remains asymp-
tomatic in children, manifesting in the early adults,
especially in presence of thrombosis risk factors [3].
Some reports describe cases of DVT due to IVC anom-
alies in children and adolescents [4-7]. There is no
standard management strategy established for patients
with DVT due to AIVC. In most cases, life-long antic-
oagulation therapy could be indicated while there are
some reports of recurrence of thrombosis after discon-
tinuation of the treatment [8]. At least in one case,
surgical correction with prosthetic venous bypass was
necessary, when pharmacological treatment for stasis
ulceration of lower limb, caused by AIVC, failed [9].
Therapeutic approach in children with DVT is different
from the strategy in adults. In children with first DVT
secondary to structural venous abnormalities either
unfractionated heparin (UFH) or low-molecular-weight
heparin (LMWH) are suggested for acute anticoagulant
therapy and ongoing treatment [10,11]. M. pneumoniae
is a common cause of community-acquired pneumonia
in school-aged children and adolescents but its associ-
ation with thrombosis is yet not well described. Previously
reported extrapulmonary manifestations rarely applied to
thrombosis and the pathophysiology of hypercoagulability
in M. pneumoniae infection remains unknown. Most of
the few reported cases of thrombosis applied to arterial
location [12]. In several cases of M. pneumoniae infec-
tion, transient antiphospholipid antibodies (aPL), such as
anticardiolipin antibodies (aCL), lupus anticoagulant and
beta-2 microglobulin antibodies, have been reported,
which might contribute to hypercoagulability [12-14].
In this article, we present a description of deep ven-
ous thrombosis associated with M.pneumoniae positive
serum antibodies, indicating early infection, and nega-
tive aCL antibodies, in adolescent with congenital ab-
sence of IVC.Case presentation
14-year old Caucasian boy was admitted to the pediatric
unit complaining with severe pain of the left hip and in-
ternal thigh area that was exacerbated by compression
and flexion of a hip. The patient was unable to walk and
stand upright. Clinical examination revealed femoral
artery pulse asymmetry with weaker left femoral pulse
combined with asymmetrically increased circumference
of the left lower limb greater by 1 cm at the levels of
mid-thigh and mid-calf. Additionally, salmon-colored
rush was spread on his trunk. 2 weeks before admission
the patient underwent appendectomy with removal of
purulent but not perforated appendix. Ultrasonography
(USG) with the Doppler probe during postoperative
period provided atypical image with difficulties in visual-
izing the inferior vena cava. The pain occurred 10 days
after surgery and was constricting the movement of the
left hip. Continuously aggravating pain was accompanied
with subfebrile temperature (<38°C [100.4°F]) and ele-
vated C-reactive protein (CRP) levels. The abdominal
USG and roentgenograms of the hip showed no abnor-
malities, but amoxicillin treatment has been initiated.
After 5 days, due to the constantly elevated CRP levels
and temperature that raised up to 38°C [100.4°F], the
patient was referred to the pediatric unit. At admission
CRP level was in 8-fold reference range, D-dimer and
fibrinogen concentrations were also elevated with values
326 μg/ml and 615 mg/dL, respectively. The ultrasonog-
raphy showed deep venous thrombosis of left lower
limb, vena cava inferior was not visualized. CT angio-
gram (Figure 1.) revealed the absence of inferior vena
cava from common iliac veins connection to the conflu-
ence of hepatic veins. The patient had a short segment
of inferior vena cava between the normal sized hepatic
veins and the right atrium. The venous drainage from
lower limbs and pelvis was found to be supplied by
collateral circulation that includes varicosely dilated
veins: azygos and hemiazygos, paraspinal and mesen-
teric. Additionally, the CT angiogram showed thrombus
within left-sided popliteal vein, femoral vein, external
and internal iliac veins and common iliac vein to the
level of L4 vertebra. Further diagnostics were conse-
quently performed. Anticardiolipin IgM and IgG anti-
bodies and antinuclear antibodies were not detected.
Tests for rheumatoid factor, anti-CCP antibodies and
thrombophilia screening, which included genetic diag-
nostics for Leiden V factor, protein C and protein S, were
also negative. The antithromobotic treatment has been
started with 80 mg of enoxaparin s.c. twice daily with ele-
vation and compression dressings for the full length of left
lower limb. Control laboratory tests performed after 2 days
of low molecular weight heparin (LMWH) treatment
revealed that CRP, D-dimer and fibrinogen concentrations
have lowered. Patient’s temperature was constantly elevated
Figure 1 CT-angiograph of 14-year old boy with absence of inferior vena cava. Scan shows lack of contrast filling at the site of vena cava
inferior. Numerous veins of collateral circulation within pelvis are varicosely dilated. Because of their atypical anatomy drainage of the renal
veins could not be identified.1. Renal confluence, 2. Dilated portal vein, 3. Inferior mesenteric vein, 4. Lack of contrast filling at the site of
inferior vena cava.
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immunoassay (EIA) in serum detected Mycoplasma
pneumoniae IgM, IgA and IgG antibodies with concen-
trations 1.258 S/CO, 25.183 EIU and 170.619 EIU, re-
spectively. This pattern is typical for the early stage of
infection. The antibiotic was changed to clarithromy-
cin p.o. with the effect of normothermia after two days
of treatment. The pain relieved, skin rash faded and
after a couple of days both disappeared. The patient
received clarithromycin in the recommended dose for
14 days. The initial antithrombotic treatment has been
continued. The patient was advised to use fitted com-
pression stocking, elevate leg at rest and avoid
thrombogenic risk factors such as strenuous physical
activity or prolonged immobilization. After 1 month,
Mycoplasma pneumoniae antibodies in classes IgM,
IgA and IgG were constantly being detected in serum
and the concentrations indicated early infection. USG
performed after 3 months of LMWH treatment
showed reduction of initial thrombosis with recanaliza-
tion of the left popliteal vein. The antithrombotic
treatment has been continued with 80 mg of enoxa-
parin s.c. twice daily with subsequent USG control
planned after following 3 months.Conclusions
AIVC is a rare vascular anomaly and the risk factor for
deep venous thrombosis, that occurs predominantly in
young adults [1,2]. There are only few descriptions of DVT
due to AIVC presentation in children [4-7]. M. pneumoniae
infection, popular among school children, might contribute
to hypercoagulability and cause thrombosis itself. The
pathophysiology of this process remains unknown, but
transient aPL antibodies, such as aCL antibodies, are often
detected in cases of DVT associated with M. pneumoniae
infection [12-14]. In our patient, 14-year-old boy, many
factors contributed to the unusual clinical presentation.
The postoperative period was not connected with pro-
longed immobilization, but purulent appendix was a site of
local inflammation before the surgery, that might have con-
tributed to hypercoagulability. Developing M.pneumonie
infection, in the presence of congenital AIVC, led to the
lower limb DVT. Uncommonly for DVT due to M. pneu-
moniae infection, serum aCL antibodies were not detected.
To our knowledge, this is the first reported case of
deep venous thrombosis associated with M.pneumoniae
serum antibodies indicating early infection with negative
aCL serum antibodies in adolescent with absence of
inferior vena cava.
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Written informed consent was obtained from parents of
the patient and the patient himself for publication of
this Case report and any accompanying images. A copy
of the written consent is available for review by the
Editor of this journal.
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